Trial ID or NCT#

NCT00767624

Status

NOT RECRUITING

Purpose

The aim of the proposed three-site study is to increase the rate of full remission from major depressive disorder (MDD) at the end of 16 weeks of treatment for people who experience both major depressive disorder and insomnia.

Investigator(s)

Rachel Manber, PhD

Contact us to find out if this trial is right for you.

CONTACT

Haddas Elisha
(650) 723-2641